drugset / Trial / NCT01173757

To Evaluate The Relationship Between Plasma Drug Levels And Receptor Binding In Brain Using PET (Positron Emission Tomography) In Healthy Volunteers

NCT01173757

Phase 1 Completed 8 enrolled Pfizer
Non-randomizedSingle-groupDouble-blindBasic science

Summary

The purpose of this study is to evaluate the relationship between plasma drug levels and receptor binding in brain using PET; and to evaluate safety and tolerability after a single administration of PF-04995274 in healthy volunteers.

Timeline

Start
2010-08
Primary completion
2010-11
Completion
2010-11

Drugs

EvaluationDrugModalityDoseRoute
Subject PF-04995274 Small molecule 5 mg

Indications

No indication recorded.